Deals this week: Theradome, Valeant Pharmaceuticals, and Colorescience

Theradome has announced a partnership with Eclipse Aesthetics to launch hair restoration product LH80 PRO helmet.

Theradome is a medical therapy company, while Eclipse Aesthetics is a supplier of aesthetic products.

Both the companies involved in the transaction are based in the US.

Valeant Pharmaceuticals has announced the sale of its skincare brands CeraVe, AcneFree, and AMBI to L'Oréal for $1.3bn.

The sale is part of a divestiture programme undertaken to focus on Valeant’s core business and meet its financial goals.

Valeant is a Canada-based manufacturer, developer, and marketer of pharmaceutical products, while L'Oréal is a cosmetics company based in France.

Colorescience has announced its collaboration with Galderma to provide innovative skincare solutions to aesthetic healthcare professionals and women.

The collaboration will provide customers with Galderma's aesthetic facial injectables and selection of Colorescience’s cosmetic and skincare products.

Based in the US, Colorescience sells cosmetic products, while Galderma is a dermatology company based in Switzerland.